Constant release rate solid oral dosage formulations of veropami

Details Constant release rate solid oral dosage formulations of veropami Constant release rate solid oral dosage formulations of veropami

1983-01-03

1984-07-24

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Identification or warning feature

Taste or smell or chemical irritation to the eye, nose, or...

424 22, 424 35, A61K 922, A61K 926

Patent

active

044617593

ABSTRACT:
A constant order release rate solid oral dosage formulation of verapamil or a pharmaceutically acceptable salt thereof, said formulation comprising: a therapeutically effective amount of verapamil; from about 0.5 to 6.0 weight percent of an acid-retardant or hydrophobic cellulose derivative; from about 2.5 to 35 weight percent of a hydrogenated vegetable oil: from about 1 to 20 weight percent of an acrylic acid polymer; from about 0.5 to 4.0 weight percent of fumed silicon dioxide and from about 0.4 to 3.0 percent of a lubricant.

REFERENCES:
patent: 3577514 (1971-05-01), Robinson
Gibson et al., CA.97 #133454a(1982).
Juslin et al., CA.96 #40847v(1982).
Khanna et al., CA.94 #127301v(1981).
Jayaswal et al., CA.93 #155800e(1980).
Chasseaud et al., CA.85 #68210d(1976).
Ekenved et al., CA.76 #1037562(1972).

Affiliated with

Also associated with

Rating

Constant release rate solid oral dosage formulations of veropami does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Constant release rate solid oral dosage formulations of veropami, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Constant release rate solid oral dosage formulations of veropami will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-97771